Schizophrenia Research
Volume 53, Issue 3 , Pages 199-207 , 15 January 2002

Assessing disturbed thinking and cognition using the Ego Impairment Index in older schizophrenia patients: paranoid vs. nonparanoid distinction

  • Lisa A Auslander

      Affiliations

    • Department of Psychiatry, University of California, San Diego, CA, USA
    • Corresponding Author InformationCorresponding author. Geriatric Psychiatry Division 116A-1, 3350 La Jolla Village Drive, San Diego, CA 92161, USA. Tel.: +1-858-552-8585 (ext 7176); fax: +1-858-552-7404
  • ,
  • William Perry

      Affiliations

    • Department of Psychiatry, University of California, San Diego, CA, USA
  • ,
  • Dilip V Jeste

      Affiliations

    • Department of Psychiatry, University of California, San Diego, CA, USA
    • Department of Neuroscience, University of California, San Diego, CA, USA
    • Veterans Affairs San Diego Health Care System, San Diego, CA, USA

Received 1 December 2000 ,Accepted 5 March 2001.

References 

  1. Andreasen N. Thought, language, and communication disorders. Arch Gen Psychiatry. 1979;36:1315–1321
  2. Andreasen N.C., 1984. The Scale for the Assessment of Positive Symptoms (SAPS), The University of Iowa, Iowa City
  3. Andreasen N, Olsen S. Negative and positive schizophrenia: Definition and validation. Arch Gen Psychiatry. 1982;39:789–793
  4. Blair JR, Spreen O. Predicting premorbid IQ: A revision of the National Adult Reading Test. The Clinical Neuropsychologist. 1989;3:129–136
  5. Bleuler E. Dementia Praecox, or the Group of Schizophrenias. New York: International Universities Press; 1950;
  6. Bornstein RA, Nasrallah HA, Olson SC, Coffman JA, Torello M, Schwarzkopf SB. Neuropsychological deficit in schizophrenic subtypes: Paranoid, nonparanoid, and schizoaffective subgroups. Psychiatry Res. 1990;31:15–24
  7. Cadenhead KS, Perry W, Braff DL. The relationship of information-processing deficits and clinical symptoms in schizotypal personality disorder. Biol Psychiatry. 1996;40:853–858
  8. Exner JE. The Rorschach: A Comprehensive System, Basic Foundations. 3rd edn, Volume 1. New York: Wiley; 1993;
  9. First, M.B., Spitzer, R.L., Gibbon, M., and Williams, J.B.W., 1995. Structured Clinical Interview for DSM-IV Axis I Disorder-Patient Edition (SCID-I/P), Biometrics Research Department, New York State Psychiatric Institute, New York.
  10. Frank G. Research on the clinical usefulness of the Rorschach: The diagnosis of schizophrenia. Percept Mot Skills. 1990;71:573–578
  11. Goldberg TE, Aloia MS, Gourovitch ML, Missar D, Pickar D, Weinberger DR. Cognitive substrates of thought disorder, I: The semantic system. Am. J. Psychiatry. 1998;155:1671–1676
  12. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology. 1967;6:278–296
  13. Harvey PD, Lenzenweger MF, Keefe RS, Pogge DL, Serper MR, Mohs RC. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: formal thought disorder. Psychiatry Res. 1992;44:141–151
  14. Jeste DV, Wyatt RJ. Understanding and Treating Tardive Dyskinesia. New York: Guilford Press; 1982;
  15. Jeste DV, Alexopoulos GS, Bartels SJ, Cummings JL, Gallo JJ, Gottlieb GL, et al. Consensus statement on the upcoming crisis in geriatric mental health: Research agenda for the next two decades. Arch Gen Psychiatry. 1999;56:848–853
  16. Johnston MH, Holzman PS. Assessing Schizophrenia Thinking. San Francisco: Jossey-Bass; 1979;
  17. Koh SD, Kayton L. Memorization of “unrelated” word strings by young nonpsychotic schizophrenics. J. Abnorm. Psychol. 1974;83:14–22
  18. Lazar BS, Harrow M. Paranoid and nonparanoid schizophrenia: Drive dominated thinking and thought pathology at two phases of disorder. J. Clin Psychol. 1985;41:145–151
  19. Lezak MD. Neuropsychological Assessment. 3rd Ed. New York: Oxford University Press; 1995;
  20. Magaro P. The paranoid and the schizophrenic: The case for distinct cognitive style. Schizophr Bull. 1981;7:632–661
  21. Mattis, S., 1973. Dementia Rating Scale, Psychological Assessment Resources, Inc, Odessa, FL.
  22. McAdams LA, Harris MJ, Heaton SC, Bailey A, Fell R, Jeste DV. Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients. Schizophr Res. 1997;27:219–226
  23. McDowell DJ, Reynolds B, Magaro PA. The integration defect in paranoid and nonparanoid schizophrenia. J Abnorm Psychol. 1975;84:629–636
  24. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1:30–46
  25. National Institute of Mental Health, 1975. Abnormal Involuntary Movement Scale (AIMS). Early Clinical Drug Evaluation Unit Intercom 4, 3–6.
  26. O'Carroll RO, Walker M, Dunan J, Murray C, Blackwood D, Ebmeier K, et al. Selecting controls for schizophrenia research studies: The use of the national adult reading test. Schizophr Res. 1992;8:137–141
  27. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799–812
  28. Palmer BW, Heaton SC, Jeste DV. Older patients with schizophrenia: Challenges in the coming decades. Psychiatr Serv. 1999;50:1178–1183
  29. Patterson TL, Kaplan RM, Grant I, Semple SJ, Moscona S, Koch WL, et al. Quality of well-being in late-life psychosis. Psychiatry Res. 1996;63:169–181
  30. Paulsen JS, Romero R, Chan A, Davis AV, Heaton RK, Jeste DV. Impairment of the semantic network in schizophrenia. Psychiatry Res. 1996;63:109–121
  31. Perry W, Braff D. Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry. 1994;151:363–367
  32. Perry W, Viglione D. The Ego Impairment Index as a Predictor of Outcome in Melancholic Depressed Patients Treated with Tricylic Antidepressants. J Pers Assess. 1991;56:487–501
  33. Perry W, Viglione D, Braff D. The Ego Impairment Index and Schizophrenia: A Validation Study. J Pers Assess. 1992;59:165–175
  34. Perry W, McDougall A, Viligone DA. Five year follow-up on the temporal stability of the Ego Impairment Index. J Pers Assess. 1995;64:112–118
  35. Perry W, Potterat E, Auslander L, Kaplan E, Jeste DV. A neuropsychological approach to the Rorschach in patients with dementia of the Alzheimer type. Assessment. 1996;3:351–363
  36. Perry W, Geyer M, Braff D. Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenia patients. Arch Gen Psychiatry. 1999;56:277–281
  37. Racenstein JM, Penn D, Harrow M, Schleser R. Thought disorder and psychosocial functioning in schizophrenia: The concurrent and predictive relationship. Journal of Nervous and Mental Disease. 1999;187:281–289
  38. Rappaport M, Hopkins HK, Hall K. Auditory signal detection in paranoid and nonparanoid schizophrenics. Arch Gen Psychiatry. 1972;27:747–752
  39. Rorschach H. Pschodiagnostics: A diagnostic test based on perception. Bern: Hans Huber; 1942;
  40. Seltzer J, Conrad C, Cassens G. Neuropsychological profiles in schizophrenia: Paranoid versus undifferentiated distinctions. Schizophr Res. 1997;23:131–138
  41. Shrout PE, Fleiss JL. Intraclass correlations: Uses in assessing rater reliability. Psychol Bull. 1979;86:420–428
  42. Spohn HE, Coyne L, Larson J, Mittleman F, Spray J, Hayes K. Episodic and residual thought pathology in chronic schizophrenics: Effect of neuroleptics. Schizophr Bull. 1986;12:394–407
  43. Tsuang MT, Leaverton PE, Huang KS. Criteria for subtyping poor prognosis schizophrenia: A numerical model for differentiating paranoid from non-paranoid schizophrenia. J Psychiatr Res. 1974;10:189–197
  44. Van Sweden B, Van Erp MG, Mesotten F, Crevits L. Impaired early visual processing in disorganized schizophrenia. Acta Neurol Belg. 1998;98:17–20
  45. Young MA, Meltzer HY. The relationship of demographic, clinical and outcome variables to neuroleptic treatment requirements. Schizophr Bull. 1980;6:88–101
  46. Zigler E, Levine J, Zigler B. Premorbid social competence and paranoid-nonparanoid status in female schizophrenic patients. Journal of Nervous and Mental Disease. 1977;164:333–339

PII: S0920-9964(01)00209-2

Schizophrenia Research
Volume 53, Issue 3 , Pages 199-207 , 15 January 2002